600064.SS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:00):

Stats
Šios dienos apimtis	24.46M
Vidutinė apimtis	14.93M
Rinkos kapitalizacija	10.90B
EPS	CNY0.296 ( 2023-10-30 )
Kita pelno data	( CNY0 ) 2024-05-23
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	5.00
ATR14	CNY0.0120 (0.19%)

Tūris Koreliacija

Ilgas: -0.17 (neutral)

Trumpas: 0.12 (neutral)

Signal:(48.365) Neutral

Nanjing Gaoke Company Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Nanjing Gaoke Company Koreliacija - Valiuta/Žaliavos

0.21
( neutral )

0.15
( neutral )

0.00
( neutral )

-0.53
( weak negative )

0.01
( neutral )

Nanjing Gaoke Company Finansinės ataskaitos

Annual	2023
Pajamos:	CNY4.73B
Bruto pelnas:	CNY589.17M (12.45 %)
EPS:	CNY0.900

FY	2023
Pajamos:	CNY4.73B
Bruto pelnas:	CNY589.17M (12.45 %)
EPS:	CNY0.900

FY	2022
Pajamos:	CNY4.49B
Bruto pelnas:	CNY841.01M (18.73 %)
EPS:	CNY1.390

FY	2021
Pajamos:	CNY4.93B
Bruto pelnas:	CNY1.14B (23.03 %)
EPS:	CNY1.903

Financial Reports:

No articles found.

Nanjing Gaoke Company

Nanjing Gaoke Company Limited develops real estate properties in China. The company develops and sells commercial residential properties; and undertakes renovation of old communities, new roads, and mountain park construction projects. It also offers house construction, municipal engineering construction and supervision, landscaping construction and maintenance, sewage treatment, and water supply services; and property management, land development, engineering design, and environmental protection project construction services. In addition, the company is involved in the industrial investment, venture capital, securities, investment management, consulting, and other investment activities; and provision of financing services for small and medium-sized technology companies, and start entrepreneurship. Further, it engages in the production and sale of various Chinese and Western medicine preparations; medical and health care consulting and service activities; and provision of leasing houses. The company was founded in 1992 and is based in Nanjing, China.